The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non–small cell lung cancer

Expert Consensus Panel

doi:10.1016/j.jtcvs.2023.04.039

The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non–small cell lung cancer

Expert Consensus Panel

Cardiovascular & Thoracic Surgery

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Novel targeted therapy and immunotherapy drugs have recently been approved for use in patients with surgically resectable lung cancer. Accurate staging, early molecular testing, and knowledge of recent trials are critical to optimize oncologic outcomes in these patients.

Original language	English (US)
Pages (from-to)	637-654
Number of pages	18
Journal	Journal of Thoracic and Cardiovascular Surgery
Volume	166
Issue number	3
DOIs	https://doi.org/10.1016/j.jtcvs.2023.04.039
State	Published - Sep 2023

Keywords

adjuvant
clinical staging
immunotherapy
neoadjuvant
non–small cell lung cancer
surgery
targeted therapy

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jtcvs.2023.04.039

Cite this

@article{711ef0a2bcf44788b612bc41a4415ed1,

title = "The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non–small cell lung cancer",

abstract = "Novel targeted therapy and immunotherapy drugs have recently been approved for use in patients with surgically resectable lung cancer. Accurate staging, early molecular testing, and knowledge of recent trials are critical to optimize oncologic outcomes in these patients.",

keywords = "adjuvant, clinical staging, immunotherapy, neoadjuvant, non–small cell lung cancer, surgery, targeted therapy",

author = "{Expert Consensus Panel} and Biniam Kidane and Matthew Bott and Jonathan Spicer and Leah Backhus and Jamie Chaft and Neel Chudgar and Yolonda Colson and D'Amico, {Thomas A.} and Elizabeth David and Jay Lee and Sara Najmeh and Boris Sepesi and Catherine Shu and Jeffrey Yang and Scott Swanson and Brendon Stiles",

note = "Publisher Copyright: {\textcopyright} 2023 The American Association for Thoracic Surgery",

year = "2023",

month = sep,

doi = "10.1016/j.jtcvs.2023.04.039",

language = "English (US)",

volume = "166",

pages = "637--654",

journal = "Journal of Thoracic and Cardiovascular Surgery",

issn = "0022-5223",

publisher = "Mosby Inc.",

number = "3",

}

TY - JOUR

T1 - The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document

T2 - Staging and multidisciplinary management of patients with early-stage non–small cell lung cancer

AU - Expert Consensus Panel

AU - Kidane, Biniam

AU - Bott, Matthew

AU - Spicer, Jonathan

AU - Backhus, Leah

AU - Chaft, Jamie

AU - Chudgar, Neel

AU - Colson, Yolonda

AU - D'Amico, Thomas A.

AU - David, Elizabeth

AU - Lee, Jay

AU - Najmeh, Sara

AU - Sepesi, Boris

AU - Shu, Catherine

AU - Yang, Jeffrey

AU - Swanson, Scott

AU - Stiles, Brendon

PY - 2023/9

Y1 - 2023/9

N2 - Novel targeted therapy and immunotherapy drugs have recently been approved for use in patients with surgically resectable lung cancer. Accurate staging, early molecular testing, and knowledge of recent trials are critical to optimize oncologic outcomes in these patients.

AB - Novel targeted therapy and immunotherapy drugs have recently been approved for use in patients with surgically resectable lung cancer. Accurate staging, early molecular testing, and knowledge of recent trials are critical to optimize oncologic outcomes in these patients.

KW - adjuvant

KW - clinical staging

KW - immunotherapy

KW - neoadjuvant

KW - non–small cell lung cancer

KW - surgery

KW - targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85163334262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85163334262&partnerID=8YFLogxK

U2 - 10.1016/j.jtcvs.2023.04.039

DO - 10.1016/j.jtcvs.2023.04.039

M3 - Article

C2 - 37306641

AN - SCOPUS:85163334262

SN - 0022-5223

VL - 166

SP - 637

EP - 654

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

IS - 3

ER -

The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non–small cell lung cancer

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this